The omicron variant is thought to cause less olfactory dysfunction than previous variants of
SARS-CoV-2, but the reported prevalence differs greatly between populations and studies …

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has been responsible for a devastating pandemic since March …

Olfactory capacity declines with aging, but increasing evidence shows that smell dysfunction
is one of the early signs of prodromal neurodegenerative diseases such as Alzheimer's and …

Introduction Current approved COVID-19 vaccines, notably mRNA and adenoviral vectored
technologies, still fail to fully protect against infection and transmission of various SARS-CoV …

Highlights•Neurological manifestations can occur in around 30% of COVID-19
patients.•Several CNS cells meet the requirements for neurotropic infection by SARS-CoV …

Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Since the start of the …

During the first waves of the coronavirus disease 2019 (COVID-19) pandemic caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, olfactory …

Cohort studies that quantify volumetric brain data among individuals with different levels of
COVID-19 severity are presently limited. It is still uncertain whether there exists a potential …

The prevalence of olfactory dysfunction (OD) in people infected with the omicron variant is
substantially reduced compared with previous variants. However, four recent studies …

People often confuse smell loss with taste loss, so it is unclear how much gustatory function
is reduced in patients self-reporting taste loss. Our pre-registered cross-sectional study …